Skip to content

Added to your cart:

Cart subtotal

View cart (2) Checkout
Cancer Treating Drugs Hikma Pharmaceuticals Leukemia and Lymphoma Medications
Click or scroll to zoom
Tap or pinch to zoom
Mercaptopurine Tablets 50 mg by Hikma
Mercaptopurine Tablets 50 mg by Hikma

Mercaptopurine Tablets 50 mg USP 25 Count

by Hikma
SKU 00054-4581-11
Sale 23%
$ 64.95
$ 49.95
In stock
Non-Returnable
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

✔ Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 23%
$ 64.95
$ 49.95
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Mercaptopurine Tablets 50 mg USP 25 Count
Mercaptopurine Tablets 50 mg USP 25 Count
$ 64.95 $ 49.95
🔒 Medical License Required

Cancer Treating Drugs

Hikma Pharmaceuticals

Leukemia and Lymphoma Medications

Description

Mercaptopurine Tablets by Hikma are a critical component in the management of certain leukemias. These tablets provide a reliable oral chemotherapy option aimed at inhibiting cancer cell proliferation in acute lymphoblastic leukemia (ALL).

Usage: Mercaptopurine is primarily used in the treatment of acute lymphoblastic leukemia. It may also be prescribed as part of maintenance therapy in suitable regimens for other hematologic cancers.

Dosage:

  • Standard Dosage: Typically 1.5 to 2.5 mg/kg of body weight per day, administered as a single dose.
  • Dosage adjustments may be necessary based on tolerance and response.
  • Always follow the specific dosing instructions provided by a healthcare provider.

CDC Guidelines: The CDC highlights the importance of individualized cancer treatment plans and regular monitoring of blood counts during chemotherapy. Proper handling and administration procedures should be followed to ensure patient safety and efficacy.

Details and Features:

  • Strength: 50 mg per tablet
  • Count: 25 tablets per bottle
  • Oral Chemotherapy: Convenient for outpatient management
  • Effective Leukemia Management: Targets cell proliferation in hematologic malignancies

Mechanism of Action: Mercaptopurine interferes with nucleotide synthesis by incorporating into DNA and RNA, inhibiting the synthesis and function of purine nucleotides. This disrupts the growth and replication of cancer cells, leading to cell death.

Directions for Use:

  • Take tablets orally with or without food.
  • Maintain a consistent dosing schedule as prescribed by the healthcare provider.
  • Regular blood tests are required to monitor response and adjust dosage.

Warnings:

  • Monitor liver function and blood counts regularly due to the risk of toxicity.
  • Use with caution in patients with hepatic or renal impairment.
  • Avoid use in patients with known hypersensitivity to mercaptopurine.

Side Effects: Possible side effects include:

  • Bone marrow suppression
  • Liver toxicity
  • Nausea
  • Vomiting
  • Rash In the case of severe adverse reactions, seek immediate medical assistance.

Mercaptopurine Tablets by Hikma provide a trusted and effective option in the fight against leukemia, supporting patient outcomes through targeted therapeutic action.

Description

Mercaptopurine Tablets by Hikma are a critical component in the management of certain leukemias. These tablets provide a reliable oral chemotherapy option aimed at inhibiting cancer cell proliferation in acute lymphoblastic leukemia (ALL).

Usage: Mercaptopurine is primarily used in the treatment of acute lymphoblastic leukemia. It may also be prescribed as part of maintenance therapy in suitable regimens for other hematologic cancers.

Dosage:

  • Standard Dosage: Typically 1.5 to 2.5 mg/kg of body weight per day, administered as a single dose.
  • Dosage adjustments may be necessary based on tolerance and response.
  • Always follow the specific dosing instructions provided by a healthcare provider.

CDC Guidelines: The CDC highlights the importance of individualized cancer treatment plans and regular monitoring of blood counts during chemotherapy. Proper handling and administration procedures should be followed to ensure patient safety and efficacy.

Details and Features:

  • Strength: 50 mg per tablet
  • Count: 25 tablets per bottle
  • Oral Chemotherapy: Convenient for outpatient management
  • Effective Leukemia Management: Targets cell proliferation in hematologic malignancies

Mechanism of Action: Mercaptopurine interferes with nucleotide synthesis by incorporating into DNA and RNA, inhibiting the synthesis and function of purine nucleotides. This disrupts the growth and replication of cancer cells, leading to cell death.

Directions for Use:

  • Take tablets orally with or without food.
  • Maintain a consistent dosing schedule as prescribed by the healthcare provider.
  • Regular blood tests are required to monitor response and adjust dosage.

Warnings:

  • Monitor liver function and blood counts regularly due to the risk of toxicity.
  • Use with caution in patients with hepatic or renal impairment.
  • Avoid use in patients with known hypersensitivity to mercaptopurine.

Side Effects: Possible side effects include:

  • Bone marrow suppression
  • Liver toxicity
  • Nausea
  • Vomiting
  • Rash In the case of severe adverse reactions, seek immediate medical assistance.

Mercaptopurine Tablets by Hikma provide a trusted and effective option in the fight against leukemia, supporting patient outcomes through targeted therapeutic action.

People Also Searched For

Carboplatin Injection 150 mg / 15 mL Multiple Dose Vial 15 mL (RX) Carboplatin Injection 450 mg / 45 mL Multi-dose Vial 45 mL, Preservative Free (RX) Gardasil 9 Human Papillomavirus Vaccine (HPV vaccine) Recombinant, 20 mcg - 60 mcg (10-Pack) **Requires Refrigeration (RX) Dexamethasone Sodium Phosphate Injection 1 mL (Decadron Shot) 25/Pack (Rx) Neulasta (pegfilgrastim) Shot 6 mg Syringe Fareston Tablets 60 mg Methotrexate Injection 250 mg/mL Vial 10 mL (RX) Methotrexate Sodium Injection 50 mg Per 2 mL (25 mg/mL) Multi-Dose Vials 2 mL x 5/Pack (RX) Megestrol Acetate 20 mg Tablets by Teva (RX) Cytarabine Injection 1000 mg per 50 mL Multi-dose Vial 50 mL by Pfizer Injectables (RX)

Reviewed by 16K+ Customers

4.63 ★ (18088)
Verified

Get Notified When Back in Stock